PLXDC2 Protein, Human (HEK293, His)

PLXDC2 protein potentially contributes to tumor angiogenesis, influencing blood vessel formation in tumors. It interacts with CTTN, suggesting involvement in cellular activities related to cytoskeletal dynamics and cell migration. PLXDC2 Protein, Human (HEK293, His) is the recombinant human-derived PLXDC2 protein, expressed by HEK293, with C-His labeled tag. The total length of PLXDC2 Protein, Human (HEK293, His) is 424 a.a., with molecular weight of 75-95 kDa.

PLXDC2 protein may play a significant role in tumor angiogenesis, potentially influencing the process of blood vessel formation within tumor tissues. Additionally, it interacts with CTTN, suggesting a possible involvement in cellular activities associated with cytoskeletal dynamics and cell migration.

Human

HEK293

C-His

Q6UX71-1 (K31-A454)

/

75-95 kDa

Greater than 95% as determined by reducing SDS-PAGE.

Lyophilized powder.

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. Normally 8% trehalose is added as protectant before lyophilization.

<1 EU/μg, determined by LAL method.

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH₂O.

Stored at -20°C for 2 years. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Room temperature in continental US; may vary elsewhere.